NFE2L2 and Alzheimer disease: Further studies are needed to dissect the complexity of targets that are controlled by BACH1/Nrf2 signaling and the potential mechanisms that are relevant to aging and neurodegeneration not only in DS but also in AD and, potentially, in other neurodegenerative disorders.